Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,961 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04984330 | Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease(STARR) | withdrawn | Early Phase 1 | 0 | Weill Medical College of Cornell UniversityOTHER | 1 | Nov 17, 2022 | clinicaltrials |
| NCT04776980 | Multimodality MRI and Liquid Biopsy in GBM | withdrawn | Early Phase 1 | 0 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Sep 16, 2022 |
| NCT05395260 | FL- 101 Study in Non-Metastatic MIBC | withdrawn | Early Phase 1 | 0 | Flame BiosciencesINDUSTRY | 0 | Aug 19, 2022 | clinicaltrials |
| NCT04288336 | Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy | withdrawn | Early Phase 1 | 0 | Mayo ClinicOTHER | 1 | Jul 11, 2022 | clinicaltrials |
| NCT04891718 | CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia | withdrawn | Early Phase 1 | 0 | Presage BiosciencesINDUSTRY | 1 | Jul 8, 2022 | clinicaltrials |
| NCT01371240 | Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity | withdrawn | Early Phase 1 | 0 | University Hospitals Cleveland Medical CenterOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT04630210 | Investigating Atezolizumab in Newly Diagnosed ER Positive Breast Cancer Patients According to Their AdipOsity(AteBrO) | withdrawn | Early Phase 1 | 0 | Universitaire Ziekenhuizen KU LeuvenOTHER | 0 | Jun 15, 2022 | clinicaltrials |
| NCT04803630 | Thermal Therapy for the Treatment of Depression in Cancer Survivors, the S-WARM Study | withdrawn | Early Phase 1 | 0 | Roswell Park Cancer InstituteOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT04186988 | [18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed Therapy | withdrawn | Early Phase 1 | 0 | University of California, DavisOTHER | 0 | Feb 1, 2022 | clinicaltrials |
| NCT05061251 | Surgical Window of Opportunity Study of Orally Administered BAY 2402234 in Recurrent Glioma | withdrawn | Early Phase 1 | 0 | University of Texas Southwestern Medical CenterOTHER | 0 | Jan 11, 2022 | clinicaltrials |
| NCT03548727 | Pseudo-Simultaneous Imaging of Tumor Hypoxia and Proliferation in HNC Patients Using PET/CT | withdrawn | Early Phase 1 | 0 | Weill Medical College of Cornell UniversityOTHER | 1 | Dec 29, 2021 | clinicaltrials |
| NCT01331616 | Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab | withdrawn | Early Phase 1 | 0 | West Penn Allegheny Health SystemOTHER | 0 | Dec 9, 2021 | clinicaltrials |
| NCT04223648 | Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma | withdrawn | Early Phase 1 | 0 | Yale UniversityOTHER | 0 | Nov 22, 2021 | clinicaltrials |
| NCT04677361 | Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab | withdrawn | Early Phase 1 | 0 | Fox Chase Cancer CenterOTHER | 0 | Oct 8, 2021 | clinicaltrials |
| NCT02857218 | Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer | withdrawn | Early Phase 1 | 0 | OHSU Knight Cancer InstituteOTHER | 0 | Sep 16, 2021 | clinicaltrials |
| NCT04403568 | Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate | withdrawn | Early Phase 1 | 0 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Sep 16, 2021 | clinicaltrials |
| NCT01967927 | Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor Therapy | withdrawn | Early Phase 1 | 0 | University of ArkansasOTHER | 1 | Aug 19, 2021 | clinicaltrials |
| NCT03980249 | Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells | withdrawn | Early Phase 1 | 0 | West Virginia UniversityOTHER | 1 | Apr 12, 2021 | clinicaltrials |
| NCT03536208 | Biological Effect of Warfarin on Pancreatic Cancer | withdrawn | Early Phase 1 | 0 | University of Texas Southwestern Medical CenterOTHER | 1 | Mar 25, 2021 | clinicaltrials |
| NCT03718650 | Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer | withdrawn | Early Phase 1 | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT03295695 | PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient | withdrawn | Early Phase 1 | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 4, 2020 | clinicaltrials |
| NCT02699723 | Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer | withdrawn | Early Phase 1 | 0 | Jean Yuh TangOTHER | 0 | Oct 22, 2020 | clinicaltrials |
| NCT03556930 | Simulated Radiotherapy Treatment Assisted With Pediatric Radiation Oncology With Movie Induced Sedation Effect Technique | withdrawn | Early Phase 1 | 0 | University of Texas Southwestern Medical CenterOTHER | 0 | Aug 27, 2020 | clinicaltrials |
| NCT04220892 | Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma | withdrawn | Early Phase 1 | 0 | Jose CarrilloOTHER | 1 | Jul 31, 2020 | clinicaltrials |
| NCT04285749 | Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas | withdrawn | Early Phase 1 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Jul 27, 2020 | clinicaltrials |
| NCT04088032 | Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer | withdrawn | Early Phase 1 | 0 | Alison StopeckOTHER | 1 | Jul 16, 2020 | clinicaltrials |
| NCT03613259 | Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma | withdrawn | Early Phase 1 | 0 | OHSU Knight Cancer InstituteOTHER | 0 | Jun 9, 2020 | clinicaltrials |
| NCT03574220 | Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer | withdrawn | Early Phase 1 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Apr 7, 2020 | clinicaltrials |
| NCT03022565 | Vorinostat in Patients With Class 2 High Risk Uveal Melanoma | withdrawn | Early Phase 1 | 0 | University of MiamiOTHER | 0 | Feb 6, 2020 | clinicaltrials |
| NCT04051047 | Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma | withdrawn | Early Phase 1 | 0 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 27, 2019 | clinicaltrials |
| NCT03906838 | Regional Anesthesia Block in Fibula Free Flap Reconstruction | withdrawn | Early Phase 1 | 0 | University of FloridaOTHER | 1 | Jul 18, 2019 | clinicaltrials |
| NCT03291353 | Phase 0- Pilot Study of Pembrolizumab on Immune Cells in Patient With Refractory Acute Myeloid Leukemia | withdrawn | Early Phase 1 | 0 | Michael BoyiadzisOTHER | 1 | Apr 19, 2019 | clinicaltrials |
| NCT02610920 | Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection | withdrawn | Early Phase 1 | 0 | Columbia UniversityOTHER | 0 | Mar 26, 2019 | clinicaltrials |
| NCT03193463 | Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy | withdrawn | Early Phase 1 | 0 | Michael Vogelbaum, MD, PhDOTHER | 0 | Mar 1, 2019 | clinicaltrials |
| NCT03388814 | Speeding Recovery From Pain and Opioid Use | withdrawn | Early Phase 1 | 0 | Wake Forest University Health SciencesOTHER | 0 | Nov 30, 2018 | clinicaltrials |
| NCT02442739 | Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers | withdrawn | Early Phase 1 | 0 | Cedars-Sinai Medical CenterOTHER | 1 | Nov 6, 2018 | clinicaltrials |
| NCT02971410 | Simvastatin in Overcoming Chemotherapy Resistance in Patients With Relapsed or Refractory Multiple Myeloma | withdrawn | Early Phase 1 | 0 | Wake Forest University Health SciencesOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT02872519 | PET Imaging of Ovarian Carcinoma With 18F-FSPG | withdrawn | Early Phase 1 | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Jun 6, 2018 | clinicaltrials |
| NCT03235869 | Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma | withdrawn | Early Phase 1 | 0 | University of Michigan Rogel Cancer CenterOTHER | 1 | Mar 15, 2018 | clinicaltrials |
| NCT01933269 | FACBC for Head and Neck Cancers | withdrawn | Early Phase 1 | 0 | Emory UniversityOTHER | 0 | Feb 5, 2018 | clinicaltrials |
| NCT02774512 | Predictive Biomarkers of Biological Activity and Efficacy of Nilotinib on ZAK Target in Non-metastatic Colon Cancer(ZAK-0) | withdrawn | Early Phase 1 | 0 | Institut BergoniéOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT02593929 | Pharmacodynamic Effects and Predictive Biomarkers With Ruxolitinib in Operable Head and Neck Cancer | withdrawn | Early Phase 1 | 0 | University of PittsburghOTHER | 0 | Jun 8, 2017 | clinicaltrials |
| NCT01784042 | Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue | withdrawn | Early Phase 1 | 0 | Milton S. Hershey Medical CenterOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT02735798 | 64-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets | withdrawn | Early Phase 1 | 0 | Pamela MunsterOTHER | 0 | May 4, 2017 | clinicaltrials |
| NCT00993642 | ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer | withdrawn | Early Phase 1 | 0 | Tulane University Health Sciences CenterOTHER | 1 | Mar 13, 2017 | clinicaltrials |
| NCT02976441 | Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas | withdrawn | Early Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Feb 20, 2017 | clinicaltrials |
| NCT02805868 | Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis | withdrawn | Early Phase 1 | 0 | Northwestern UniversityOTHER | 0 | Oct 24, 2016 | clinicaltrials |
| NCT02419170 | Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC) | withdrawn | Early Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Jul 18, 2016 | clinicaltrials |
| NCT02447055 | Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma | withdrawn | Early Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Jul 12, 2016 | clinicaltrials |
| NCT02277457 | Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations | withdrawn | Early Phase 1 | 0 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 24, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Nov 17, 2022source: clinicaltrials